Condoliase

DB12793InvestigationalProtein Based Therapies

Condoliase has been used in trials studying the treatment of Lumbar Disc Disease, Lumbar Vertebra Hernia, and Intervertebral Disc Disease.

Mechanism
Curator reviewed
Code names
SI-6603

Resolves to

Compound
UNII7SI2UZG934CAS9024-13-9
Clinical / RWD
RxNorm1546420

What you can answer from here — as of July 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Condoliase, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In